Get In Touch
Our team is ready to help you. Share your details, and we’ll get back to you promptly.
By submitting this form, you acknowledge that you have read and agree to our Privacy Policy.
Advisory
Bringing a MedTech product to market is a complex endeavor that requires alignment across multiple business functions, from R&D to commercialization. At Credent Partners, we support MedTech innovators in designing and executing their Go-to-Market (GTM) strategies with a systemic approach rooted in the SEAM method.
Why Credent?
With deep experience in MedTech strategy, regulatory affairs, and digital platforms like Salesforce, Credent Partners combines systemic thinking with hands-on execution. Our approach helps MedTech startups—from seed to Series C—move efficiently and confidently from innovation to adoption.
Our Approach.
We use the SEAM method to define how MedTech companies should go to market — from acquisition to termination — and validate operational coherence using Michael Porter’s Value Chain. The SEAM method was developed by the Laboratory of Systemic Modelling at Swiss Federal Institute of Technology in Lausanne (EPFL), one of the top 10 of Engineering Schools in Europe.
SEAM is a family of methods designed for strategic thinking, business-IT alignment, and requirements engineering. It enables the analysis and design of strategies across business, inter-company, company, and IT system levels.
This framework ensures a clear understanding of how value is delivered to customers throughout the product’s life, from acquisition to termination.
Get In Touch.
We appreciate your interest in Credent. If you have any specific questions or wish to discuss a particular challenge you are faced with or to find out more about how the SEAM framework may help in developing your GTM plan, contact us now.